C12N 9/6413
Aspartic endopeptidases
Official title: {Aspartic endopeptidases (3.4.23)}
C12N9/6413 (Aspartic endopeptidases) appears on 5 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 20
- Assignees
- 16
- Inventors
- 58
- Latest grant
- 20 Apr 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 0 | 1 |
| 2005 | 1 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered mammalian cells for production of recombinant proteins20 Apr 2021US 10,982,191 B2Danmarks Tekniske Universitet
- Peptides that modulate complex SASPase-FLG222 Mar 2016US 9,290,553 B2L'oreal
- Saspase knockout animal16 Nov 2010US 7,834,238 B2Eisai R&D Management Co., Ltd.
- Asp222 Mar 2005US 6,870,030 B2SmithKline Beecham Corporation
- Asp220 Nov 2001US 6,319,689 B1SmithKline Beecham Corporation
- Recombinant milk polypeptide compositions free of aspartyl protease activity4 Jun 2026US 2026/0152753 A1Dsm IP Assets B.V.
- Plants expressing proteins of animal origin and associated processes and methods2 Oct 2025US 2025/0304987 A1Agrivida, Inc.
- Methods for decellularizing animal tissue and bioinks derived therefrom30 Jan 2025US 2025/0034413 A1Virginia Commonwealth University
- Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-194 May 2023US 2023/0137756 A1
- Synthetic alpha-secretase and use thereof8 Dec 2022US 2022/0389400 A1Gwangju Institute of Science and Technology
Most cited
By later US patents